Novartis pledges $33.7 million to HBCUs for health equity
Global pharmaceutical company Novartis and the Novartis US Foundation have announced a commitment of $33.7 million over ten years to address the root causes of disparities in health and education and co-create effective, measurable solutions for health equity.To get more novartis latest news, you can visit shine news official website.
The commitment includes partnerships with Coursera, the National Medical Association, Thurgood Marshall College Fund, Morehouse School of Medicine (MSM), and twenty-six historically Black colleges and universities and HBCU medical schools to co-develop programs focused on building trust in the healthcare system with communities of color and making measurable progress toward health equity. The collaboration will focus on improving access to high-quality education, technology, improved health outcomes, and promising jobs; increasing diversity in clinical trials and among the investigators who conduct the trials; addressing inherent bias in the data standards; and focusing on issues that disproportionately affect health among communities of color. To that end, the company and its foundation will award a total of $20 million in support of scholarships, mentorships, and research grants and $13.7 million to establish three digitally enabled research centers at MSM, including a clinical trial center of excellence with the potential to serve as a model for possible expansion.
"Black and African-American people endured education and health disparities in the United States long before the COVID-19 pandemic. Their exclusion from the research and development ecosystem has resulted in mistrust and a delayed uptake of life-saving innovative medicines and effective care models, further exacerbating racial disparities in care and outcomes," said Novartis US Foundation president Patrice Matchaba. "We are proud to come together to take our direction from Black and African-American community members and other minority groups on programs that will help achieve sustained change."
"Health equity is not only accessible health care for patients but developing educational and professional opportunities to create a diverse pipeline of educators, clinicians, and other professionals, as well as ensuring all are included in clinical studies," said MSM president and CEO Valerie Montgomery Rice. "This is a first of its kind collaboration and Morehouse School of Medicine is excited to work with Novartis and this coalition of medical schools, colleges, universities, and other leading companies and organizations to create centers of excellence for clinical trials, data standards research, and environment and health research. We know that real change starts here, when work is done to make a significant impact on representation and inclusion."